Controlling malaria: Challenges and solutions

Tropical Medicine and International Health

Volumn 6, Issue 11, 2001, Pages 922-927

  Olliaro, Piero ^a   Taylor, Walter R J ^a,b   Rigal, Jean ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Artemisinin; Malaria; Resistance; Sub Saharan Africa

Indexed keywords

AMODIAQUINE; ARTEMISININ; ARTESUNATE; CHLOROQUINE; DOXYCYCLINE; FANSIDAR; HALOFANTRINE; MEFLOQUINE; QUININE;

DISEASE CONTROL; DISEASE TREATMENT; MALARIA; PUBLIC HEALTH;

AFRICA; ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG USE; HEALTH CARE POLICY; HUMAN; MALARIA; MALARIA CONTROL; MONOTHERAPY; MULTIDRUG RESISTANCE; PLASMODIUM FALCIPARUM; TREATMENT FAILURE; WORLD HEALTH ORGANIZATION;

ADVISORY COMMITTEES; AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; ARTEMISININS; BIOLOGICAL MARKERS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; ENDPOINT DETERMINATION; EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; MALARIA; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; SESQUITERPENES; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ARTESUNATE; CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0034776148     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2001.00752.x     Document Type: Article

References (28)

1. Making malaria treatment policy in the face of drug resistance
2. Beyond chloroquine: Implications of drug resistance for evaluating malaria therapy efficacy and treatment policy
3. Guidelines for the prevention of malaria in travellers from the United Kingdom
4. Multi-drug resistant falciparum malaria in Cameroon in 1987-1988. II. Mefloquine resistance confirmed in vivo and in vitro and its correlation with quinine resistance
5. Guidelines for managing HIV infection
6. Community based approaches to the control of multidrug resistant tuberculosis: Introducing 'DOTS-plus'
7. In vivo efficacy study of amodiaquine and sulfadoxine/pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania
8. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa
9. Plasmodium falciparum-associated anemia in children at a large urban hospital in Zaire
10. Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: Correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes
11. Malaria as a re-emerging disease
12. Sulfa-doxine-pyrimethamine efficacy for uncomplicated falciparum malaria in Malawi after seven years as first line therapy
13. Drug resistant malaria, with special reference to Thailand
14. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: A prospective study
15. Efficacy of sulphadoxine/pyrimethamine for Plasmodium falciparum malaria in Malawian children under five years of age
16. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania
17. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population
18. Evaluation of antimalarial drugs in Indonesia, 1981-1995
19. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon region of Brazil
20. Antimalarial drug resistance: The pace quickens
21. Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives
22. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo
23. Preventing antimalarial drug resistance through combinations
24. Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malaria
25. Averting a malaria disaster
26. World malaria situation in 1994
27. Childhood mortality during an after hospitaliation in western Kenya: Effect of malaria treatment regimens